Rezan Abdul Kadir

Rezan Abdul Kadir

Auto-generated profile, based on publicly available information

Rezan Abdul Kadir

The Royal Free Hospital

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2021 in Blood Advances
Verified
Journal Article
Closed access
NCNathan T. Connell
Nathan T. Connell
VFVeronica H. Flood
Veronica H. Flood
RBRomina Brignardello-Petersen
Romina Brignardello-Petersen
RARezan Abdul-Kadir
Rezan Abdul-Kadir
AAAlice Arapshian
Alice Arapshian
RMReem A. Mustafa
Reem A. Mustafa
Background: von Willebrand disease (VWD) is a common inherited bleeding disorder. Significant variability exists in management options offered to patients.Objective: These evidence-based guidelines from the American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), the National Hemophilia Foundation (NHF), and the World Federation of Hemophilia (WFH) are intended to support patients, clinicians, and health care professionals in their decisions about management of VWD.Methods: ASH, ISTH, NHF, and WFH formed a multidisciplinary guideline panel. Three patient representatives were included. The panel was balanced to minimize potential bias from conflicts of interest. The University of Kansas Outcomes and Implementation Research Unit and the McMaster Grading of Recommendations Assessment, Development and Evaluation (GRADE) Centre supported the guideline development process, including performing and updating systematic evidence reviews (through November 2019). The panel prioritized clinical questions and outcomes according to their importance to clinicians and patients. The panel used the GRADE approach, including GRADE Evidence-to-Decision frameworks, to assess evidence and make recommendations, which were subject to public comment.Results: The panel agreed on 12 recommendations and outlined future research priorities.Conclusions: These guidelines make key recommendations regarding prophylaxis for frequent recurrent bleeding, desmopressin trials to determine therapy, use of antiplatelet agents and anticoagulant therapy, target VWF and factor VIII activity levels for major surgery, strategies to reduce bleeding during minor surgery or invasive procedures, management options for heavy menstrual bleeding, management of VWD in the context of neuraxial anesthesia during labor and delivery, and management in the postpartum setting.

1 January 2016 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
PCPeter Collins
Peter Collins
RAR. Abdul‐Kadir
R. Abdul‐Kadir
JTJecko Thachil
Jecko Thachil

30 August 2020 in International Journal of Gynecology & Obstetrics
Verified
Journal Article
Open access
PDF file
OTOzlem Turan
Ozlem Turan
AHAmir Hakim
Amir Hakim
PDPradip Dashraath
Pradip Dashraath
WJWong Jing Lin Jeslyn
Wong Jing Lin Jeslyn
AWAlison Wright
Alison Wright
RARezan Abdul‐Kadir
Rezan Abdul‐Kadir
Background: Pregnant women represent a potentially high‐risk population in the COVID‐19 pandemic.Objective: To summarize clinical characteristics and outcomes among pregnant women hospitalized with COVID‐19.Search strategy: Relevant databases were searched up until May 29, 2020.Selection criteria: Case series/reports of hospitalized pregnant women with laboratory‐confirmed COVID‐19.Data collection and analysis: PRISMA guidelines were followed. Methodologic quality was assessed via NIH assessment tools.Main results: Overall, 63 observational studies of 637 women (84.6% in third trimester) with laboratory‐confirmed SARS‐CoV‐2 infection were included. Most (76.5%) women experienced mild disease. Maternal fatality, stillbirth, and neonatal fatality rates were 1.6%, 1.4%, and 1.0%, respectively. Older age, obesity, diabetes mellitus, and raised serum D‐dimer and interleukin‐6 were predictive of poor outcomes. Overall, 33.7% of live births were preterm, of which half were iatrogenic among women with mild COVID‐19 and no complications. Most women underwent cesarean despite lacking a clear indication. Eight (2.0%) neonates had positive nasopharyngeal swabs after delivery and developed chest infection within 48 hours.Conclusions: Advanced gestation, maternal age, obesity, diabetes mellitus, and a combination of elevated D‐dimer and interleukin‐6 levels are predictive of poor pregnancy outcomes in COVID‐19. The rate of iatrogenic preterm birth and cesarean delivery is high; vertical transmission may be possible but has not been proved.

3 August 2021 in Haemophilia
Verified
Journal Article
Open access
PDF file
KGKarin van Galen
Karin van Galen
MLMichelle Lavin
Michelle Lavin
NSNaja Skouw‐Rasmussen
Naja Skouw‐Rasmussen
KFKathelijn Fischer
Kathelijn Fischer
DNDeclan Noone
Declan Noone
T(the European Haemophilia Consortium (EHC) and the European Association for Haemophilia and Allied Disorders (EAHAD)
the European Haemophilia Consortium (EHC) and the European Association for Haemophilia and Allied Disorders (EAHAD)
Introduction: Despite increasing awareness of issues faced by women and girls with inherited BDs (WGBD), standards of care are lacking, with disparities in diagnosis and treatment for WGBD across Europe. We aimed to develop practical principles of care (PoC) to promote standardization of care for WGBD within European Haemophilia Treatment and Comprehensive Care Centres (HTC/CCCs).Methods: The co‐creation process, supported by the European Association for Haemophilia and Allied Disorders, consisted of four multidisciplinary meetings with health care providers (HCPs) experienced in WGBD care, and European Haemophilia Consortium representatives, combined with broad patient and HCP consultations in the European haemophilia community. Relevant medical societies outside Europe were contacted for confirmation.Results: We developed ten PoC for WGBD, stressing the importance and benefits of a centralized, multidisciplinary, comprehensive, family‐centred approach to support and manage WGBD during all life stages. These PoC emphasise the right to equitable access and quality of care for all people with BDs, irrespective of gender. Multiple medical societies outside Europe also confirmed their support for endorsement.Conclusions: Ten PoC for WGBD evolved from an iterative process among stakeholders, supported by relevant medical societies worldwide. These PoC can serve as a benchmark for diagnosis and comprehensive multidisciplinary management of WGBD, and improve awareness of their unique challenges. They offer a framework to guide HTC/CCCs in providing equitable care for all WGBD, both in their own services and in other healthcare settings. Implementation of these principles aims to positively impact the health, wellbeing and quality of life for WGBD.

28 August 2013 in Haemophilia
Verified
Journal Article
Closed access
PDF file
LSL. A. T. Sharief
L. A. T. Sharief
RKR. A. Kadir
R. A. Kadir

9 October 2013 in Haemophilia
Verified
Journal Article
Open access
PDF file
RKR. A. Kadir
R. A. Kadir
JDJ. Davies
J. Davies
RWR. Winikoff
R. Winikoff
DPD. Pollard
D. Pollard
FPFlora Peyvandi
Flora Peyvandi
AFA. B. Federici
A. B. Federici
Summary: Women with inherited bleeding disorders (IBD) require the input of a multidisciplinary team to improve outcomes of pregnancy. The role of the haemophilia nurse within the multidisciplinary team is to provide educational and emotional support to the women and to facilitate and co‐ordinate patient‐centred care. Prenatal diagnosis in cases of haemophilia is an integral part of the management of early pregnancy with a recent drive towards non‐invasive prenatal diagnostic techniques. There is a current lack of data on the risk of miscarriage and bleeding complications during pregnancy. A clear association has only been established in women with fibrinogen and factor XIII deficiency. In the affected neonate with severe bleeding disorders such as haemophilia, the risk of head bleeding is significant, and appropriate management of labour and delivery has an important impact on reducing the risk. Women withIBDare at risk of both primary and secondary postpartum haemorrhage. Appropriate risk assessment and advance planning for haemostatic cover can reduce the bleeding risk.